14nov 21Koliek-5 Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.
download
← Terug naar overzichtdownload
← Terug naar overzicht